Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 8, Issue 3, 2014, Pages 138-144

  Berezin, Alexander E ^a   Kremzer, Alexander A ^a  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Chronic heart failure; Endothelial progenitor cells; Insulin resistance

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOPOIETIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; CD309 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IVABRADINE; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYMPHOCYTE ANTIGEN; MINERALOCORTICOID ANTAGONIST; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PTPRC PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL COUNT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC CHRONIC HEART FAILURE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PHENOTYPE; PREDICTIVE VALUE; SMOKING; SYSTOLIC BLOOD PRESSURE; ANGIOCARDIOGRAPHY; CHRONIC DISEASE; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; UKRAINE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIGENS, CD14; ANTIGENS, CD34; ANTIGENS, CD45; BIOLOGICAL MARKERS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; UKRAINE;

EID: 84907761650     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.07.001     Document Type: Article

References (35)

1. G. Santulli Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts JCvD 1 1 2013 1 2
2. E. Braunwald Heart failure JACC Heart Fail 1 1 2013 1 20
3. M. Bastien, P. Poirier, I. Lemieux, and J.P. Després Overview of epidemiology and contribution of obesity to cardiovascular disease Prog Cardiovasc Dis 56 4 2014 369 381
4. I. Shimizu, Y. Yoshida, T. Katsuno, and T. Minamino Adipose tissue inflammation in diabetes and heart failure Microbes Infect 15 1 2013 11 17
5. H. Tsutsui, S. Kinugawa, and S. Matsushima Oxidative stress and heart failure Am J Physiol Heart Circ Physiol 301 6 2011 H2181 H2190
6. T. Oka, H. Akazawa, A.T. Naito, and I. Komuro Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure Circ Res 114 3 2014 565 571
7. E. Ingelsson, J. Sundström, J. Arnlöv, B. Zethelius, and L. Lind Insulin resistance and risk of congestive heart failure JAMA 294 3 2005 334 341
8. E. Ingelsson, J. Arnlöv, J. Sundström, B. Zethelius, B. Vessby, and L. Lind Novel metabolic risk factors for heart failure J Am Coll Cardiol 46 11 2005 2054 2060
9. H. Tuunanen, E. Engblom, A. Naum, M. Scheinin, K. Någren, and J. Airaksinen Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction J Card Fail 12 8 2006 644 652
10. I. Shimizu, Y. Yoshida, T. Katsuno, K. Tateno, S. Okada, and J. Moriya p53-Induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure Cell Metab 15 1 2012 51 64
11. J. Arnlöv, L. Lind, B. Zethelius, B. Andrén, C.N. Hales, and B. Vessby Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up Am Heart J 142 2001 720 724
12. A.E. Berezin, and A.A. Kremzer Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure J Card Fail March 2014 10.1016/j.cardfail.2014.02.009 [Epub ahead of print], pii:S1071-9164(14)00080-3
13. A.E. Berezin, A.A. Kremzer, T.A. Samura, and Y.V. Martovitskaya Apoptotic microparticles to progenitor mononuclear cells ratio in heart failure: relevance of clinical status and outcomes JCvD 2 1 2014 [Epub ahead of print]
14. O. Amir, I. Spivak, I. Lavi, and M.A. Rahat Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients Mediators Inflamm 2012 2012 616384
15. G.P. Fadini, I. Baesso, M. Albiero, S. Sartore, C. Agostini, and A. Avogaro Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau Atherosclerosis 197 2 2008 496 503
16. K.K. Hirschi, D.A. Ingram, and M.C. Yoder Assessing identity, phenotype, and fate of endothelial progenitor cells Arterioscler Thromb Vasc Biol 28 9 2008 1584 1595
17. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, and A.A. Quyyumi Circulating endotelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600
18. + cells identifies a population of functional endothelial precursors Blood 95 2000 952 958
19. G.P. Fadini, S. Maruyama, T. Ozaki, A. Taguchi, J. Meigs, and S. Dimmeler Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis PLoS ONE 5 2010 e11488
20. C. Schmidt-Lucke, L. Rossig, S. Fichtlscherer, M. Vasa, M. Britten, and U. Kämper Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair Circulation 111 22 2005 2981 2987
21. D.A. Bluemke, S. Achenbach, M. Budoff, T.C. Gerber, B. Gersh, and L.D. Hillis Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young Circulation 118 2008 586 606
22. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of two-dimensional echocardiograms J Am Soc Echocardiogr 2 1989 358 367
23. D. Pellerin, R. Sharma, P. Elliott, and C. Veyrat Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function Heart 89 90003 2003 iii9 iii17
24. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2012 1 266
26. J.W. Tung, D.R. Parks, W.A. Moore, L.A. Herzenberg, and L.A. Herzenberg New approaches to fluorescence compensation and visualization of FACS data Clin Immunol 110 3 2004 277 283
27. D.K. McGuire, and M.O. Gore Insulin resistance and risk for incident heart failure JACC Heart Fail 1 6 2013 537 539
28. N. Giuseppina, P. Marinella, V. Claudia, S. Pietro, F. Marianna, and D.M. Riccardo Early subclinical ventricular dysfunction in patients with insulin resistance J Cardiovasc Med (Hagerstown) 15 2 2014 110 114
29. O. Vardeny, D.K. Gupta, B. Claggett, Burke S1, A. Shah, and L. Loehr Insulin resistance and incident heart failure: the ARIC study (Atherosclerosis Risk in Communities) JACC Heart Fail 1 6 2013 531 536
30. Q. Xiao, S. Kiechl, S. Patel, F. Oberhollenzer, S. Weger, and A. Mayr Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: results from a large population-based study PLoS ONE 2 2007 e975 e980
31. + cell count and metabolic syndrome synergistically increase the risk of adverse outcomes Atherosclerosis 207 2009 213 219
32. C. Bakogiannis, D. Tousoulis, E. Androulakis, A. Briasoulis, N. Papageorgiou, and G. Vogiatzi Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes Curr Med Chem 19 16 2012 2597 2604
33. H.R. Chang, J.C. Hsieh, B.G. Hsu, L.Y. Wang, M.Y. Chen, and J.H. Wang Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure PLOS ONE 8 11 2013 e79096
34. N. Toda, and T. Okamura Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview J Clin Pharmacol 53 12 2013 1228 1239
35. S. Devaraj, and I. Jialal Dysfunctional endothelial progenitor cells in metabolic syndrome Exp Diabetes Res 2012 2012 585018